Zimmer Biomet Holdings Inc (ZBH)

Debt-to-assets ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	5,341,600	4,737,700	3,956,700	4,826,200	4,867,900	5,127,400	5,189,400	5,204,800	5,152,200	5,055,200	5,172,000	5,286,300	5,463,700	6,458,100	6,802,500	7,538,700	7,626,500	7,840,200	7,759,300	7,724,200
Total assets	US$ in thousands	21,365,300	21,720,300	21,520,000	21,452,400	21,496,900	21,217,300	21,294,300	21,243,500	21,066,000	21,333,300	21,452,700	21,617,500	23,456,400	24,008,600	24,223,200	24,026,600	24,417,700	24,025,500	23,647,600	25,512,900
Debt-to-assets ratio		0.25	0.22	0.18	0.22	0.23	0.24	0.24	0.25	0.24	0.24	0.24	0.24	0.23	0.27	0.28	0.31	0.31	0.33	0.33	0.30

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $5,341,600K ÷ $21,365,300K
= 0.25

Zimmer Biomet Holdings Inc has shown a fluctuating trend in its debt-to-assets ratio over the analyzed period from March 31, 2020, to December 31, 2024. The ratio started at 0.30 in March 2020 and increased to 0.33 by June 2020 and remained stable at this level until September 2020. There was a slight decrease in the ratio to 0.31 by December 2020, which continued to decline consistently to 0.23 by December 2021.

From March 2022 to June 2024, the debt-to-assets ratio fluctuated within a narrower range, remaining between 0.22 and 0.28. Notably, there was a significant decrease to 0.18 by June 2024, which was the lowest point during the analyzed period.

Overall, the decreasing trend from 0.30 in March 2020 to 0.18 by June 2024 indicates that Zimmer Biomet Holdings Inc has been managing its debt relative to its assets effectively. A lower debt-to-assets ratio suggests that the company has a lower level of financial leverage and may be relatively less risky for creditors. However, it is essential to consider this ratio in conjunction with other financial metrics to gain a comprehensive understanding of the company's financial health and risk profile.